Literature DB >> 15231695

Dibutyryl cyclic adenosine monophosphate restores the ability of aged Leydig cells to produce testosterone at the high levels characteristic of young cells.

Haolin Chen1, June Liu, Lindi Luo, Barry R Zirkin.   

Abstract

The wealth of knowledge about the function and regulation of adult Leydig cells, the cells within the mammalian testis that produce testosterone, make these cells ideal for studying principles and mechanisms of aging. A hallmark of mammalian aging is decreased serum testosterone concentration. In the Brown Norway rat, this has been shown to be associated with the reduced ability of aged Leydig cells to produce testosterone in response to LH. Herein, we demonstrate that culturing the aged cells with dibutyryl cAMP, a membrane-permeable cAMP agonist that bypasses the LH receptor-adenlyly cyclase cascade, restores testosterone production to levels comparable to those of young cells and also restores steroidogenic acute regulatory protein and P450scc, the proteins involved in the rate-limiting steps of steroidogenesis. These results strongly suggest that signal transduction deficits are responsible for reduced steroidogenesis by aged Leydig cells and that bypassing signal transduction reverses the steroidogenic decline by the aged cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231695     DOI: 10.1210/en.2004-0639

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Knockout of the transcription factor Nrf2: Effects on testosterone production by aging mouse Leydig cells.

Authors:  Haolin Chen; Shiying Jin; Jingjing Guo; Ponvijay Kombairaju; Shyam Biswal; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2015-03-25       Impact factor: 4.102

2.  The opposing roles of nitric oxide and cGMP in the age-associated decline in rat testicular steroidogenesis.

Authors:  Srdjan J Sokanovic; Aleksandar Z Baburski; Marija M Janjic; Natasa J Stojkov; Maja M Bjelic; Dusan Lalosevic; Silvana A Andric; Stanko S Stojilkovic; Tatjana S Kostic
Journal:  Endocrinology       Date:  2013-07-24       Impact factor: 4.736

Review 3.  Aging and declining testosterone: past, present, and hopes for the future.

Authors:  Barry R Zirkin; Joyce Lisa Tenover
Journal:  J Androl       Date:  2012-08-09

Review 4.  Leydig cell aging and hypogonadism.

Authors:  M C Beattie; L Adekola; V Papadopoulos; H Chen; B R Zirkin
Journal:  Exp Gerontol       Date:  2015-02-18       Impact factor: 4.032

Review 5.  Steroidogenesis in Leydig cells: effects of aging and environmental factors.

Authors:  Yiyan Wang; Fenfen Chen; Leping Ye; Barry Zirkin; Haolin Chen
Journal:  Reproduction       Date:  2017-07-26       Impact factor: 3.906

6.  Aging has the opposite effect on cAMP and cGMP circadian variations in rat Leydig cells.

Authors:  Aleksandar Z Baburski; Srdjan J Sokanovic; Silvana A Andric; Tatjana S Kostic
Journal:  J Comp Physiol B       Date:  2016-12-03       Impact factor: 2.200

7.  Effect of glutathione depletion on Leydig cell steroidogenesis in young and old brown Norway rats.

Authors:  Haolin Chen; Angela S Pechenino; June Liu; Matthew C Beattie; Terry R Brown; Barry R Zirkin
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

8.  Steroidogenic fate of the Leydig cells that repopulate the testes of young and aged Brown Norway rats after elimination of the preexisting Leydig cells.

Authors:  Haolin Chen; Jingjing Guo; Renshan Ge; Qingquan Lian; Vassilios Papadopoulos; Barry R Zirkin
Journal:  Exp Gerontol       Date:  2015-09-01       Impact factor: 4.032

Review 9.  Leydig cells: From stem cells to aging.

Authors:  Haolin Chen; Ren-Shan Ge; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2009-02-07       Impact factor: 4.102

10.  Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.